2023 Speakers

View the 25+ expert speakers at the
12th Tumour Models London Summit 2023.

Adam Drake

Head of In Vivo Pharmacology

Ichnos Science

Anna Erkstam

Chief Executive Officer

BioReperia

Christophe Boudesco

Associate Research Director of Translational Research

Exscientia

Clive Roper

Director, Roper Toxicology Consulting Limited, & Vice President

ESTIV

David Gomez Jimenez

Scientist

Alligator Bioscience

Etienne De Braekeleer

Senior Scientist

AstraZeneca

Fabien Garcon

Senior Scientist

AstraZeneca

Francesca Barone

Chief Scientific Officer

Candel Therapeutics

Gabriel van der Pluijm

Head of Urology Research Laboratory

Leiden University Medical Center

Jianming Xu

Director of Functional Pharmacology Center

GemPharmatech

Jonathan Hollick

Managing Director and Head of Research

Breakpoint Therapeutics

Josh Caggiula

VP of Client Relations

LIDE

Kader Thiam

Senior Vice President Discovery - Preclinical Models & Services

GenOway

Kainat Khan

Associate Director

AstraZeneca

Livija Deban

Chief Scientific Officer

Prokarium

Louis Gall

Senior Scientist

AstraZeneca

Louise Ramos

Scientist

Rakovina Therapeutics

Marc van Dijk

Chief Scientific Officer

MiNK Therapeutics

Michael Boice

Senior Director, Scientific Engagement and Key Accounts

Certis Oncology

Nicholas Glanville

Vice President - Research

Prokarium

Paula Costales Vigil

Senior Scientist

Artios Pharma

Philipp Metzger

Senior Director - Study and In Vivo Pharmacology

Reaction Biology

Rita Fior

Group Leader

Champalimaud Foundation

Rose Ann Padua

Director

INSERM

Sheri Barnes

Head, Scientific Development, Preclinical Oncology

LabCorp

Sumit Kumar

Senior Scientist

AstraZeneca

Tomasz Grabowski

Head, Preclinical Development

JJP Biologics